These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23547129)

  • 1. Neurologic assessment after fibrinolytic therapy for myocardial infarction.
    Mahanes D
    Crit Care Nurse; 2013 Apr; 33(2):78-80. PubMed ID: 23547129
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating as early as possible with thrombolysis is crucial, but can we do better in the sub-4.5-hour time window?
    Parsons MW
    Cerebrovasc Dis; 2011; 31(3):229. PubMed ID: 21178346
    [No Abstract]   [Full Text] [Related]  

  • 3. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
    García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J
    An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project.
    Huynh T; Cox JL; Massel D; Davies C; Hilbe J; Warnica W; Daly PA;
    Am Heart J; 2004 Jul; 148(1):86-91. PubMed ID: 15215796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombolysis in stroke].
    Diener HC; Hacke W
    Internist (Berl); 1996 Jun; 37(6):613-8. PubMed ID: 8767994
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():641-6. PubMed ID: 12735044
    [No Abstract]   [Full Text] [Related]  

  • 8. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The number needed to harm: is it too optimistic?
    Mancini GB; Schulzer M
    Can J Cardiol; 2004 Nov; 20(13):1375; author reply 1376. PubMed ID: 15612137
    [No Abstract]   [Full Text] [Related]  

  • 10. How should intravenous thrombolytic agents for acute myocardial infarction be selected?
    Topol EJ
    Cardiovasc Clin; 1990; 21(1):57-75; discussion 76-8. PubMed ID: 2143103
    [No Abstract]   [Full Text] [Related]  

  • 11. [Time is still brain: the ball is in the court of neurovascular interventionist treatment].
    Calleja-Puerta S; Vega-Villar J
    Rev Neurol; 2013 Mar; 56(6):305-8. PubMed ID: 23483463
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of bolus vs infusion thrombolytic therapy.
    Graumlich JF
    JAMA; 2001 Apr; 285(16):2075. PubMed ID: 11311083
    [No Abstract]   [Full Text] [Related]  

  • 13. Intra-arterial Therapy in the Early Treatment of Acute Ischaemic Stroke.
    Kappelle LJ; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):1-2. PubMed ID: 26363971
    [No Abstract]   [Full Text] [Related]  

  • 14. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.
    Giugliano RP; McCabe CH; Antman EM; Cannon CP; Van de Werf F; Wilcox RG; Braunwald E;
    Am Heart J; 2001 May; 141(5):742-50. PubMed ID: 11320361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3).
    Curtis JP; Alexander JH; Huang Y; Wallentin L; Verheugt FW; Armstrong PW; Krumholz HM; Van de Werf F; Danays T; Cheeks M; Granger CB;
    Am J Cardiol; 2004 Aug; 94(3):279-83. PubMed ID: 15276088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should you thrombolyse all or any stroke patients with baseline National Institutes of Health stroke scale scores < or = 5?
    Steffenhagen N; Hill MD; Poppe AY; Buchan AM; Coutts SB
    Cerebrovasc Dis; 2009; 28(2):201-2. PubMed ID: 19571531
    [No Abstract]   [Full Text] [Related]  

  • 18. TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction.
    Johnson TJ
    S D J Med; 2000 May; 53(5):185-6. PubMed ID: 10835948
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute myocardial infarction. A guide for North Carolina doctors.
    Williams ML; O'Meara JJ; Tate DA; Simpson RJ
    N C Med J; 1995 Aug; 56(8):390-7. PubMed ID: 7566193
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of a severe hypofibrinogenemia induced by alteplase in two patients thrombolysed for stroke.
    Matrat A; De Mazancourt P; Derex L; Nighoghossian N; Ffrench P; Rousson R; Hanss M
    Thromb Res; 2013 Jan; 131(1):e45-8. PubMed ID: 23199548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.